Advance Pharmaceutical In a

Form 483 issued December 2, 2015 · Holtsville, New York

Inspection
Nov 12 – Dec 2, 2015
Observations
11
Pages
7
FEI number
2434807

In short: On December 2, 2015, FDA issued a Form 483 with 11 observations to Advance Pharmaceutical In a in Holtsville, New York (FEI 2434807) after an inspection that ran Nov 12 – Dec 2, 2015. The investigators were Clarisse K. Green and Robert A. Mier. Most observations concern quality system and production; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).

At a glance

Quality system and production account for 7 of 11 observations.

Quality system4
Production3
Laboratory controls2
Facilities & equipment2

What FDA observed

Preview: the opening words of each observation
  1. 01

    Control procedures are not established which validate the performance of those manufacturing processes that may be…

  2. 02

    The written stability testing…

  3. 03

    The responsibilities and procedures applicable to the quality control unit…

  4. 04

    There are no written procedures for production and process controls designed to assure that the drug…

7 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Advance Pharmaceutical In a?

FDA listed 11 observations on this Form 483, mostly about quality system, production and laboratory controls. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.

Who inspected Advance Pharmaceutical In a?

Clarisse K. Green and Robert A. Mier are named on this Form 483, for the inspection of Nov 12 – Dec 2, 2015. Each investigator has a profile showing what they cite most.

When was Advance Pharmaceutical In a inspected by FDA?

The inspection ran Nov 12 – Dec 2, 2015, and the Form 483 is dated December 2, 2015.

How do I get the full Form 483 for Advance Pharmaceutical In a?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free